Upload Image (Max 20MB per Image)
Medgenics has filed an investigational new drug (IND) application with the FDA to initiate a Phase IIb multi-center, 100-patient clinical trial. The trial is designed to evaluate the safety and efficacy of sustained erythropoietin (EPO) ...
Tags: EPODURE, EPO, Medgenics